PG: 4% organic sales growth and broad-based gains; rising costs keep FY27 guidance cautious

Procter & Gamble (P&G) reported Q1 adjusted earnings of $2.00 per share, beating estimates, with revenue of $23.28 billion also topping forecasts. The company maintained its fiscal 2027 organic sales and EPS growth outlooks but raised its all-in sales growth outlook to 2%-4% due to its acquisition of Thorne. P&G also increased its estimated fiscal 2027 after-tax commodity cost headwind to $1.4 billion.

TD Cowen raised its price target for Procter & Gamble (NYSE:PG) to $166 from $150, citing strong Q1 performance and potential for full-year guidance. The firm maintained a Hold rating due to uncertainty about U.S. momentum. PG reported Q1 earnings of $2.00 per share on $23.28B revenue, exceeding estimates. Morgan Stanley also raised its target to $185, highlighting profit upside.

Procter & Gamble (PG) reported Q1 fiscal 2027 earnings of $2.00 per share, beating estimates, with revenues up 4% to $23.28 billion. Management highlighted organic growth but cautioned about rising commodity costs. PG maintained its full-year outlook, expecting 1-3% organic sales growth and 0-3% core earnings growth. Higher costs are pressuring margins, with a projected $1.9 billion after-tax headwind.

Procter & Gamble (PG) reported Q1 2027 earnings with organic sales growth of 4% and volume growth of 2%. Margins declined due to higher costs, with a $1.4B after-tax impact expected for fiscal '27. Guidance suggests a deceleration in organic sales growth to 3% in the first half. CFO Andre Schulten attributed margin improvements to productivity gains and restructuring. Challenges include commodity cost headwinds, foreign exchange, and higher interest expenses.

Procter & Gamble (P&G) reports higher-than-expected costs due to oil prices, reducing fiscal 2027 profits by $1.4B. Despite this, sales of beauty and household products remain strong, with overall performance exceeding predictions.

Procter & Gamble (PG) reported Q1 2027 earnings with organic sales up 4.0% and core EPS at $2.00. All 10 product categories and six regions grew. Margins declined due to higher costs. FY27 guidance: 1-3% sales growth, 0-3% core EPS growth, and $15 billion in cash returns. Commodity and FX headwinds are expected to impact earnings.